treatment options for postmenopausal osteoporosis

Clicks: 166
ID: 213514
2012
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Garry M WalshDivision of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, United KingdomTo serve our readership better, future editions of Therapeutics and Clinical Risk Management will once again feature the Editor’s comments and views on some of the articles published in that issue of the journal.Bone is a complex tissue that, in addition to protecting vital organs and giving mechanical support for muscles and joints, provides a mineral reservoir essential for calcium homeostasis, together with the microenvironment essential for hematopoiesis. Osteoporosis is the most common metabolic bone disease, with up to a third of postmenopausal women suffering from this increasingly important public health problem. Key characteristics include low bone mineral density with microarchitectural deterioration of bone tissue leading to increased susceptibility to fragility fractures.
Reference Key
gm2012therapeuticstreatment Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Walsh GM
Journal liver transplantation : official publication of the american association for the study of liver diseases and the international liver transplantation society
Year 2012
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.